Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
50.71
-0.65 (-1.27%)
At close: Oct 14, 2026, 4:00 PM EDT
51.25
+0.54 (1.06%)
Pre-market: Oct 15, 2026, 5:32 AM EDT
Bright Minds Biosciences Employees
Bright Minds Biosciences had 26 employees as of September 30, 2025. The number of employees increased by 25 or 2,500.00% compared to the previous year.
Employees
26
Change (1Y)
25
Growth (1Y)
2,500.00%
Revenue / Employee
n/a
Profits / Employee
-$663,789
Market Cap
490.53M
Employees Chart
| Date | Employees | Change (1Y) | Growth (1Y) |
|---|---|---|---|
| Sep 30, 2025 | 26 | 25 | 2,500.00% |
| Sep 30, 2024 | 1 | - | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 620 |
| REGENXBIO | 371 |
| Puma Biotechnology | 179 |
| DBV Technologies | 170 |
| Aclaris Therapeutics | 73 |
| CytomX Therapeutics | 69 |
| Shattuck Labs | 40 |
| Faeth Therapeutics | 29 |
DRUG News
- 1 hour ago - Bright Minds initiated with an Outperform at Wolfe Research - TheFly
- 14 days ago - Bright Minds Biosciences to Participate in the 2026 FPWR Research Symposium and PWS Family Conference - GlobeNewsWire
- 17 days ago - Bright Minds initiated with an Outperform at LifeSci Capital - TheFly
- 5 weeks ago - Bright Minds Biosciences to Present at Upcoming Conferences - GlobeNewsWire
- 2 months ago - Bright Minds Biosciences MD&A: Q3 2026 - Filings
- 2 months ago - Bright Minds Biosciences Report: Q3 2026 - Filings
- 2 months ago - Vistagen Appoints Douglas J. Williamson to its Board of Directors - GlobeNewsWire
- 3 months ago - New Options Listings: Bright Minds Biosciences (DRUG) - GuruFocus